FDA approves Abbott TriClip TEER system
Abbott (NYSE: ABT) announced that the FDA granted approval for its first-of-ts-kind TriClip transcatheter edge-to-edge repair (TEER) system.
Source: massdevice.com
📰 Edwards Evoque News
Edwards Evoque News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Edwards Evoque. Real-time updates on events, politics, business and more.
FDA advisory committee votes in favor of Abbott TriClip
Abbott (NYSE: ABT) announced today that an FDA advisory committee ruled that the benefits of its TriClip outweigh the risks.
Source: massdevice.com
Edwards wins FDA approval for Evoque replacement tricuspid valve
Edwards Lifesciences (NYSE:EW) announced today that the FDA granted approval for its Evoque tricuspid valve replacement system.
Source: massdevice.com
Edwards announces positive results for Evoque valve replacement
Edwards Lifesciences (NYSE:EW) announced that one-year results from the TRISCEND study demonstrated favorable outcomes.
Source: massdevice.com
Pascal Tricuspid Repair Outcomes Durable at 1 Year: CLASP-TR
Three-fourths of patients had at least a two-grade reduction in tricuspid regurgitation, and 88% were alive 1 year after treatment with the experimental device.
Source: medscape.com